Passage Bio’s common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the Company’s existing trading symbol “PASG” with a new CUSIP number of 702712 209.

Explore Passage Bio analyst ratings and price targets (NASDAQ:PASG) on Benzinga. Stay updated on expert opinions and forecasts for PASG stock.

Passage Bio’s common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the Company’s existing trading symbol “PASG” with a new CUSIP number of 702712 209.

Passage Bio’s common stock will begin trading on a post-reverse stock split basis on July 14, 2025, under the Company’s existing trading symbol 'PASG” with a new CUSIP number of 702712 209. The ...

PHILADELPHIA - Passage Bio, Inc. (NASDAQ:PASG) announced Thursday that its Board of Directors has approved a 1-for-20 reverse stock split effective July 14, 2025, in an effort to regain compliance ...

Get the detailed quarterly/annual income statement for Passage Bio, Inc. (PASG). Find out the revenue, expenses and profit or loss over the last fiscal year.

Passage Bio announces a 1-for-20 reverse stock split effective July 14, 2025, to comply with Nasdaq requirements.